Limits...
Lespedeza davurica (Lax.) Schindl. extract protects against cytokine-induced β-cell damage and streptozotocin-induced diabetes.

Sharma BR, Rhyu DY - Biomed Res Int (2015)

Bottom Line: RINm5F cells were treated with interleukin- (IL-) 1β and interferon- (IFN-) γ to induce pancreatic β-cell damage.The exposure of LD extract significantly decreased cell death, nitric oxide (NO) production, nitric oxide synthase (iNOS) expression, and nucleus factor-kappa B (NF-κB) p65 activation.In OGTT, glucose clearance levels improved by oral treatment of LD extract.

View Article: PubMed Central - PubMed

Affiliation: Department of Oriental Medicine Resources and Institute of Korean Medicine Industry, College of Natural Science, Mokpo National University, 1666 Youngsan-ro, Muan-gun, Jeonnam 534-729, Republic of Korea.

ABSTRACT
Lespedeza has been used for the management of diabetes in folklore medicine. The purpose of this study is to investigate the protective effects of the methanol extract of Lespedeza davurica (LD) on cytokine-induced β-cell damage and streptozotocin- (STZ-) induced diabetes. RINm5F cells were treated with interleukin- (IL-) 1β and interferon- (IFN-) γ to induce pancreatic β-cell damage. The exposure of LD extract significantly decreased cell death, nitric oxide (NO) production, nitric oxide synthase (iNOS) expression, and nucleus factor-kappa B (NF-κB) p65 activation. Antidiabetic effects of LD extract were observed by oral glucose tolerance test (OGTT) in normal rats and by checking the biochemical, physiological, and histopathological parameters in STZ-induced diabetic rats. In OGTT, glucose clearance levels improved by oral treatment of LD extract. The water intake, urine volume, blood glucose, and serum TG, TC, TBARS, and DPP-IV levels were significantly decreased, and liver glycogen content was significantly increased by treatment of LD extract (250 mg/kg BW) in STZ-induced diabetic rats. Also, insulin immunoreactivity of the pancreases was increased in LD extract administrated rats compared with diabetic control rats. These results indicate that LD extract may protect pancreatic β-cell damage and regulate the blood glucose in STZ-induced diabetic rats.

Show MeSH

Related in: MedlinePlus

Effects of LD extract on DPP-IV in STZ-induced diabetic rats. Values are given as means ± SE for each group of eight animals. Bars with different letters are significantly different (P < 0.05, Duncan's multiple comparison tests). LD (L. davurica) and TLB (tolbutamide) were administered at a dose of 250 mg/kg BW for 4 weeks.
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4352516&req=5

fig5: Effects of LD extract on DPP-IV in STZ-induced diabetic rats. Values are given as means ± SE for each group of eight animals. Bars with different letters are significantly different (P < 0.05, Duncan's multiple comparison tests). LD (L. davurica) and TLB (tolbutamide) were administered at a dose of 250 mg/kg BW for 4 weeks.

Mentions: As shown in Figure 5, STZ caused a significant increase in activity of serum DPP-IV enzyme by 57.3%, when compared with control rats. Oral administration of LD extract significantly decreased DPP-IV activity by 25.1% compared with diabetic rats. The effect of LD extract on DPP-IV activity was comparable to those of the reference drug, TLB.


Lespedeza davurica (Lax.) Schindl. extract protects against cytokine-induced β-cell damage and streptozotocin-induced diabetes.

Sharma BR, Rhyu DY - Biomed Res Int (2015)

Effects of LD extract on DPP-IV in STZ-induced diabetic rats. Values are given as means ± SE for each group of eight animals. Bars with different letters are significantly different (P < 0.05, Duncan's multiple comparison tests). LD (L. davurica) and TLB (tolbutamide) were administered at a dose of 250 mg/kg BW for 4 weeks.
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4352516&req=5

fig5: Effects of LD extract on DPP-IV in STZ-induced diabetic rats. Values are given as means ± SE for each group of eight animals. Bars with different letters are significantly different (P < 0.05, Duncan's multiple comparison tests). LD (L. davurica) and TLB (tolbutamide) were administered at a dose of 250 mg/kg BW for 4 weeks.
Mentions: As shown in Figure 5, STZ caused a significant increase in activity of serum DPP-IV enzyme by 57.3%, when compared with control rats. Oral administration of LD extract significantly decreased DPP-IV activity by 25.1% compared with diabetic rats. The effect of LD extract on DPP-IV activity was comparable to those of the reference drug, TLB.

Bottom Line: RINm5F cells were treated with interleukin- (IL-) 1β and interferon- (IFN-) γ to induce pancreatic β-cell damage.The exposure of LD extract significantly decreased cell death, nitric oxide (NO) production, nitric oxide synthase (iNOS) expression, and nucleus factor-kappa B (NF-κB) p65 activation.In OGTT, glucose clearance levels improved by oral treatment of LD extract.

View Article: PubMed Central - PubMed

Affiliation: Department of Oriental Medicine Resources and Institute of Korean Medicine Industry, College of Natural Science, Mokpo National University, 1666 Youngsan-ro, Muan-gun, Jeonnam 534-729, Republic of Korea.

ABSTRACT
Lespedeza has been used for the management of diabetes in folklore medicine. The purpose of this study is to investigate the protective effects of the methanol extract of Lespedeza davurica (LD) on cytokine-induced β-cell damage and streptozotocin- (STZ-) induced diabetes. RINm5F cells were treated with interleukin- (IL-) 1β and interferon- (IFN-) γ to induce pancreatic β-cell damage. The exposure of LD extract significantly decreased cell death, nitric oxide (NO) production, nitric oxide synthase (iNOS) expression, and nucleus factor-kappa B (NF-κB) p65 activation. Antidiabetic effects of LD extract were observed by oral glucose tolerance test (OGTT) in normal rats and by checking the biochemical, physiological, and histopathological parameters in STZ-induced diabetic rats. In OGTT, glucose clearance levels improved by oral treatment of LD extract. The water intake, urine volume, blood glucose, and serum TG, TC, TBARS, and DPP-IV levels were significantly decreased, and liver glycogen content was significantly increased by treatment of LD extract (250 mg/kg BW) in STZ-induced diabetic rats. Also, insulin immunoreactivity of the pancreases was increased in LD extract administrated rats compared with diabetic control rats. These results indicate that LD extract may protect pancreatic β-cell damage and regulate the blood glucose in STZ-induced diabetic rats.

Show MeSH
Related in: MedlinePlus